Table of Content

1 RNA-interference (RNAi) Introduction and Market Overview

• 1.1 Objectives of the Study
• 1.2 Overview of RNA-interference (RNAi)
• 1.3 Scope of The Study
  • 1.3.1 Key Market Segments
  • 1.3.2 Players Covered
  • 1.3.3 COVID-19's impact on the RNA-interference (RNAi) industry
• 1.4 Methodology of The Study
• 1.5 Research Data Source

2 Executive Summary

• 2.1 Market Overview
  • 2.1.1 Global RNA-interference (RNAi) Market Size, 2015 – 2020
  • 2.1.2 Global RNA-interference (RNAi) Market Size by Type, 2015 – 2020
  • 2.1.3 Global RNA-interference (RNAi) Market Size by Application, 2015 – 2020
  • 2.1.4 Global RNA-interference (RNAi) Market Size by Region, 2015 - 2025
• 2.2 Business Environment Analysis
  • 2.2.1 Global COVID-19 Status and Economic Overview
  • 2.2.2 Influence of COVID-19 Outbreak on RNA-interference (RNAi) Industry Development

3 Industry Chain Analysis

• 3.1 Upstream Raw Material Suppliers of RNA-interference (RNAi) Analysis
• 3.2 Major Players of RNA-interference (RNAi)
• 3.3 RNA-interference (RNAi) Manufacturing Cost Structure Analysis
  • 3.3.1 Production Process Analysis
  • 3.3.2 Manufacturing Cost Structure of RNA-interference (RNAi)
  • 3.3.3 Labor Cost of RNA-interference (RNAi)
• 3.4 Market Distributors of RNA-interference (RNAi)
• 3.5 Major Downstream Buyers of RNA-interference (RNAi) Analysis
• 3.6 The Impact of Covid-19 From the Perspective of Industry Chain
• 3.7 Regional Import and Export Controls Will Exist for a Long Time
• 3.8 Continued downward PMI Spreads Globally

4 Global RNA-interference (RNAi) Market, by Type

• 4.1 Global RNA-interference (RNAi) Value and Market Share by Type (2015-2020)
• 4.2 Global RNA-interference (RNAi) Production and Market Share by Type (2015-2020)
• 4.3 Global RNA-interference (RNAi) Value and Growth Rate by Type (2015-2020)
  • 4.3.1 Global RNA-interference (RNAi) Value and Growth Rate of Chemical synthesis
  • 4.3.2 Global RNA-interference (RNAi) Value and Growth Rate of In vitro transcription
  • 4.3.3 Global RNA-interference (RNAi) Value and Growth Rate of In vivo expression
• 4.4 Global RNA-interference (RNAi) Price Analysis by Type (2015-2020)

5 RNA-interference (RNAi) Market, by Application

• 5.1 Downstream Market Overview
• 5.2 Global RNA-interference (RNAi) Consumption and Market Share by Application (2015-2020)
• 5.3 Global RNA-interference (RNAi) Consumption and Growth Rate by Application (2015-2020)
  • 5.3.1 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)
  • 5.3.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)

6 Global RNA-interference (RNAi) Market Analysis by Regions

• 6.1 Global RNA-interference (RNAi) Sales, Revenue and Market Share by Regions
  • 6.1.1 Global RNA-interference (RNAi) Sales by Regions (2015-2020)
  • 6.1.2 Global RNA-interference (RNAi) Revenue by Regions (2015-2020)
• 6.2 North America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 6.3 Europe RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 6.4 Asia-Pacific RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 6.5 Middle East and Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 6.6 South America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7 North America RNA-interference (RNAi) Market Analysis by Countries

• 7.1 The Influence of COVID-19 on North America Market
• 7.2 North America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
  • 7.2.1 North America RNA-interference (RNAi) Sales by Countries (2015-2020)
  • 7.2.2 North America RNA-interference (RNAi) Revenue by Countries (2015-2020)
• 7.3 United States RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 7.4 Canada RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 7.5 Mexico RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8 Europe RNA-interference (RNAi) Market Analysis by Countries

• 8.1 The Influence of COVID-19 on Europe Market
• 8.2 Europe RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
  • 8.2.1 Europe RNA-interference (RNAi) Sales by Countries (2015-2020)
  • 8.2.2 Europe RNA-interference (RNAi) Revenue by Countries (2015-2020)
• 8.3 Germany RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 8.4 UK RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 8.5 France RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 8.6 Italy RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 8.7 Spain RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 8.8 Russia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9 Asia Pacific RNA-interference (RNAi) Market Analysis by Countries

• 9.1 The Influence of COVID-19 on Asia Pacific Market
• 9.2 Asia Pacific RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
  • 9.2.1 Asia Pacific RNA-interference (RNAi) Sales by Countries (2015-2020)
  • 9.2.2 Asia Pacific RNA-interference (RNAi) Revenue by Countries (2015-2020)
• 9.3 China RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 9.4 Japan RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 9.5 South Korea RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 9.6 India RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 9.7 Southeast Asia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 9.8 Australia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10 Middle East and Africa RNA-interference (RNAi) Market Analysis by Countries

• 10.1 The Influence of COVID-19 on Middle East and Africa Market
• 10.2 Middle East and Africa RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
  • 10.2.1 Middle East and Africa RNA-interference (RNAi) Sales by Countries (2015-2020)
  • 10.2.2 Middle East and Africa RNA-interference (RNAi) Revenue by Countries (2015-2020)
• 10.3 Saudi Arabia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 10.4 UAE RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 10.5 Egypt RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 10.6 Nigeria RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 10.7 South Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11 South America RNA-interference (RNAi) Market Analysis by Countries

• 11.1 The Influence of COVID-19 on Middle East and Africa Market
• 11.2 South America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
  • 11.2.1 South America RNA-interference (RNAi) Sales by Countries (2015-2020)
  • 11.2.2 South America RNA-interference (RNAi) Revenue by Countries (2015-2020)
• 11.3 Brazil RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 11.4 Argentina RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 11.5 Columbia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
• 11.6 Chile RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

12 Competitive Landscape

• 12.1 Tekmira Pharmaceuticals Corporation
  • 12.1.1 Tekmira Pharmaceuticals Corporation Basic Information
  • 12.1.2 RNA-interference (RNAi) Product Introduction
  • 12.1.3 Tekmira Pharmaceuticals Corporation Production, Value, Price, Gross Margin 2015-2020
• 12.2 Phio Pharmaceuticals Corp.
  • 12.2.1 Phio Pharmaceuticals Corp. Basic Information
  • 12.2.2 RNA-interference (RNAi) Product Introduction
  • 12.2.3 Phio Pharmaceuticals Corp. Production, Value, Price, Gross Margin 2015-2020
• 12.3 Quark Pharmaceuticals Inc.
  • 12.3.1 Quark Pharmaceuticals Inc. Basic Information
  • 12.3.2 RNA-interference (RNAi) Product Introduction
  • 12.3.3 Quark Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
• 12.4 Ionis Pharmaceuticals Inc.
  • 12.4.1 Ionis Pharmaceuticals Inc. Basic Information
  • 12.4.2 RNA-interference (RNAi) Product Introduction
  • 12.4.3 Ionis Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
• 12.5 Dicerna Pharmaceuticals
  • 12.5.1 Dicerna Pharmaceuticals Basic Information
  • 12.5.2 RNA-interference (RNAi) Product Introduction
  • 12.5.3 Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.6 Silence Therapeutics PLC
  • 12.6.1 Silence Therapeutics PLC Basic Information
  • 12.6.2 RNA-interference (RNAi) Product Introduction
  • 12.6.3 Silence Therapeutics PLC Production, Value, Price, Gross Margin 2015-2020
• 12.7 Qiagen NV
  • 12.7.1 Qiagen NV Basic Information
  • 12.7.2 RNA-interference (RNAi) Product Introduction
  • 12.7.3 Qiagen NV Production, Value, Price, Gross Margin 2015-2020
• 12.8 Arrowhead
  • 12.8.1 Arrowhead Basic Information
  • 12.8.2 RNA-interference (RNAi) Product Introduction
  • 12.8.3 Arrowhead Production, Value, Price, Gross Margin 2015-2020
• 12.9 Merck & Co. Inc. (Sigma Aldrich)
  • 12.9.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information
  • 12.9.2 RNA-interference (RNAi) Product Introduction
  • 12.9.3 Merck & Co. Inc. (Sigma Aldrich) Production, Value, Price, Gross Margin 2015-2020
• 12.10 ISIS Pharmaceuticals
  • 12.10.1 ISIS Pharmaceuticals Basic Information
  • 12.10.2 RNA-interference (RNAi) Product Introduction
  • 12.10.3 ISIS Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.11 Alnylam Pharmaceuticals
  • 12.11.1 Alnylam Pharmaceuticals Basic Information
  • 12.11.2 RNA-interference (RNAi) Product Introduction
  • 12.11.3 Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.12 Thermo Fisher Scientific Inc.
  • 12.12.1 Thermo Fisher Scientific Inc. Basic Information
  • 12.12.2 RNA-interference (RNAi) Product Introduction
  • 12.12.3 Thermo Fisher Scientific Inc. Production, Value, Price, Gross Margin 2015-2020
• 12.13 Benitec Biopharma Ltd
  • 12.13.1 Benitec Biopharma Ltd Basic Information
  • 12.13.2 RNA-interference (RNAi) Product Introduction
  • 12.13.3 Benitec Biopharma Ltd Production, Value, Price, Gross Margin 2015-2020
• 12.14 Arcturus Therapeutics
  • 12.14.1 Arcturus Therapeutics Basic Information
  • 12.14.2 RNA-interference (RNAi) Product Introduction
  • 12.14.3 Arcturus Therapeutics Production, Value, Price, Gross Margin 2015-2020
• 12.15 RXI Pharmaceuticals
  • 12.15.1 RXI Pharmaceuticals Basic Information
  • 12.15.2 RNA-interference (RNAi) Product Introduction
  • 12.15.3 RXI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

• 13.1 Market Driver Analysis
  • 13.1.2 Market Restraints Analysis
  • 13.1.3 Market Trends Analysis
• 13.2 Merger, Acquisition and New Investment
• 13.3 News of Product Release

14 Global RNA-interference (RNAi) Market Forecast

• 14.1 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Type (2020-2025)
  • 14.1.1 Chemical synthesis Market Value and Volume Forecast (2020-2025)
  • 14.1.2 In vitro transcription Market Value and Volume Forecast (2020-2025)
  • 14.1.3 In vivo expression Market Value and Volume Forecast (2020-2025)
• 14.2 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Application (2020-2025)
  • 14.2.1 Drug Discovery and Development Market Value and Volume Forecast (2020-2025)
  • 14.2.2 Therapeutics Market Value and Volume Forecast (2020-2025)
• 14.3 RNA-interference (RNAi) Market Analysis and Forecast by Region
  • 14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  • 14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  • 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  • 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  • 14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

• 15.1 Industry Barriers and New Entrants SWOT Analysis
  • 15.1.1 Porter’s Five Forces Analysis
  • 15.1.2 New Entrants SWOT Analysis
• 15.2 Analysis and Suggestions on New Project Investment

List of Tables and Figures

Figure Product Picture of RNA-interference (RNAi)

Table Product Specification of RNA-interference (RNAi)

Table RNA-interference (RNAi) Key Market Segments

Table Key Players RNA-interference (RNAi) Covered

Figure Global RNA-interference (RNAi) Market Size, 2015 – 2025

Table Different Types of RNA-interference (RNAi)

Figure Global RNA-interference (RNAi) Value ($) Segment by Type from 2015-2020

Figure Global RNA-interference (RNAi) Market Share by Types in 2019

Table Different Applications of RNA-interference (RNAi)

Figure Global RNA-interference (RNAi) Value ($) Segment by Applications from 2015-2020

Figure Global RNA-interference (RNAi) Market Share by Applications in 2019

Figure Global RNA-interference (RNAi) Market Share by Regions in 2019

Figure North America RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure Europe RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure Asia Pacific RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure Middle East and Africa RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure South America RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Table Global COVID-19 Status and Economic Overview

Figure Global COVID-19 Status

Figure COVID-19 Comparison of Major Countries

Figure Industry Chain Analysis of RNA-interference (RNAi)

Table Upstream Raw Material Suppliers of RNA-interference (RNAi) with Contact Information

Table Major Players Headquarters, and Service Area of RNA-interference (RNAi)

Figure Major Players Production Value Market Share of RNA-interference (RNAi) in 2019

Table Major Players RNA-interference (RNAi) Product Types in 2019

Figure Production Process of RNA-interference (RNAi)

Figure Manufacturing Cost Structure of RNA-interference (RNAi)

Figure Channel Status of RNA-interference (RNAi)

Table Major Distributors of RNA-interference (RNAi) with Contact Information

Table Major Downstream Buyers of RNA-interference (RNAi) with Contact Information

Table Global RNA-interference (RNAi) Value ($) by Type (2015-2020)

Table Global RNA-interference (RNAi) Value Share by Type (2015-2020)

Figure Global RNA-interference (RNAi) Value Share by Type (2015-2020)

Table Global RNA-interference (RNAi) Production by Type (2015-2020)

Table Global RNA-interference (RNAi) Production Share by Type (2015-2020)

Figure Global RNA-interference (RNAi) Production Share by Type (2015-2020)

Figure Global RNA-interference (RNAi) Value ($) and Growth Rate of Chemical synthesis (2015-2020)

Figure Global RNA-interference (RNAi) Value ($) and Growth Rate of In vitro transcription (2015-2020)

Figure Global RNA-interference (RNAi) Value ($) and Growth Rate of In vivo expression (2015-2020)

Figure Global RNA-interference (RNAi) Price by Type (2015-2020)

Figure Downstream Market Overview

Table Global RNA-interference (RNAi) Consumption by Application (2015-2020)

Table Global RNA-interference (RNAi) Consumption Market Share by Application (2015-2020)

Figure Global RNA-interference (RNAi) Consumption Market Share by Application (2015-2020)

Figure Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)

Figure Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)

Figure Global RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Global RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Global RNA-interference (RNAi) Sales by Regions (2015-2020)

Table Global RNA-interference (RNAi) Sales Market Share by Regions (2015-2020)

Table Global RNA-interference (RNAi) Revenue (M USD) by Regions (2015-2020)

Table Global RNA-interference (RNAi) Revenue Market Share by Regions (2015-2020)

Table Global RNA-interference (RNAi) Revenue Market Share by Regions in 2015

Table Global RNA-interference (RNAi) Revenue Market Share by Regions in 2019

Figure North America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Europe RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Asia-Pacific RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Middle East and Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure South America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure North America COVID-19 Confirmed Cases Major Distribution

Figure North America RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table North America RNA-interference (RNAi) Sales by Countries (2015-2020)

Table North America RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table North America RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table North America RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure United States RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Canada RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Mexico RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Europe COVID-19 Status

Figure Europe COVID-19 Confirmed Cases Major Distribution

Figure Europe RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Europe RNA-interference (RNAi) Sales by Countries (2015-2020)

Table Europe RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table Europe RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table Europe RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure Germany RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure UK RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure France RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Italy RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Spain RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Russia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Asia Pacific RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Sales by Countries (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure China RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Japan RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure South Korea RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure India RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Southeast Asia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Australia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Middle East RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Middle East RNA-interference (RNAi) Sales by Countries (2015-2020)

Table Middle East and Africa RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table Middle East and Africa RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table Middle East and Africa RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure Saudi Arabia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure UAE RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Egypt RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Nigeria RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure South Africa RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure South America RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table South America RNA-interference (RNAi) Sales by Countries (2015-2020)

Table South America RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table South America RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table South America RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure Brazil RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Argentina RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Columbia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Chile RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Top 3 Market Share of RNA-interference (RNAi) Companies in 2019

Figure Top 6 Market Share of RNA-interference (RNAi) Companies in 2019

Table Major Players Production Value ($) Share (2015-2020)

Table Tekmira Pharmaceuticals Corporation Profile

Table Tekmira Pharmaceuticals Corporation Product Introduction

Figure Tekmira Pharmaceuticals Corporation Production and Growth Rate

Figure Tekmira Pharmaceuticals Corporation Value ($) Market Share 2015-2020

Table Phio Pharmaceuticals Corp. Profile

Table Phio Pharmaceuticals Corp. Product Introduction

Figure Phio Pharmaceuticals Corp. Production and Growth Rate

Figure Phio Pharmaceuticals Corp. Value ($) Market Share 2015-2020

Table Quark Pharmaceuticals Inc. Profile

Table Quark Pharmaceuticals Inc. Product Introduction

Figure Quark Pharmaceuticals Inc. Production and Growth Rate

Figure Quark Pharmaceuticals Inc. Value ($) Market Share 2015-2020

Table Ionis Pharmaceuticals Inc. Profile

Table Ionis Pharmaceuticals Inc. Product Introduction

Figure Ionis Pharmaceuticals Inc. Production and Growth Rate

Figure Ionis Pharmaceuticals Inc. Value ($) Market Share 2015-2020

Table Dicerna Pharmaceuticals Profile

Table Dicerna Pharmaceuticals Product Introduction

Figure Dicerna Pharmaceuticals Production and Growth Rate

Figure Dicerna Pharmaceuticals Value ($) Market Share 2015-2020

Table Silence Therapeutics PLC Profile

Table Silence Therapeutics PLC Product Introduction

Figure Silence Therapeutics PLC Production and Growth Rate

Figure Silence Therapeutics PLC Value ($) Market Share 2015-2020

Table Qiagen NV Profile

Table Qiagen NV Product Introduction

Figure Qiagen NV Production and Growth Rate

Figure Qiagen NV Value ($) Market Share 2015-2020

Table Arrowhead Profile

Table Arrowhead Product Introduction

Figure Arrowhead Production and Growth Rate

Figure Arrowhead Value ($) Market Share 2015-2020

Table Merck & Co. Inc. (Sigma Aldrich) Profile

Table Merck & Co. Inc. (Sigma Aldrich) Product Introduction

Figure Merck & Co. Inc. (Sigma Aldrich) Production and Growth Rate

Figure Merck & Co. Inc. (Sigma Aldrich) Value ($) Market Share 2015-2020

Table ISIS Pharmaceuticals Profile

Table ISIS Pharmaceuticals Product Introduction

Figure ISIS Pharmaceuticals Production and Growth Rate

Figure ISIS Pharmaceuticals Value ($) Market Share 2015-2020

Table Alnylam Pharmaceuticals Profile

Table Alnylam Pharmaceuticals Product Introduction

Figure Alnylam Pharmaceuticals Production and Growth Rate

Figure Alnylam Pharmaceuticals Value ($) Market Share 2015-2020

Table Thermo Fisher Scientific Inc. Profile

Table Thermo Fisher Scientific Inc. Product Introduction

Figure Thermo Fisher Scientific Inc. Production and Growth Rate

Figure Thermo Fisher Scientific Inc. Value ($) Market Share 2015-2020

Table Benitec Biopharma Ltd Profile

Table Benitec Biopharma Ltd Product Introduction

Figure Benitec Biopharma Ltd Production and Growth Rate

Figure Benitec Biopharma Ltd Value ($) Market Share 2015-2020

Table Arcturus Therapeutics Profile

Table Arcturus Therapeutics Product Introduction

Figure Arcturus Therapeutics Production and Growth Rate

Figure Arcturus Therapeutics Value ($) Market Share 2015-2020

Table RXI Pharmaceuticals Profile

Table RXI Pharmaceuticals Product Introduction

Figure RXI Pharmaceuticals Production and Growth Rate

Figure RXI Pharmaceuticals Value ($) Market Share 2015-2020

Table Market Driving Factors of RNA-interference (RNAi)

Table Merger, Acquisition and New Investment

Table Global RNA-interference (RNAi) Market Value ($) Forecast, by Type

Table Global RNA-interference (RNAi) Market Volume Forecast, by Type

Figure Global RNA-interference (RNAi) Market Value ($) and Growth Rate Forecast of Chemical synthesis (2020-2025)

Figure Global RNA-interference (RNAi) Market Volume ($) and Growth Rate Forecast of Chemical synthesis (2020-2025)

Figure Global RNA-interference (RNAi) Market Value ($) and Growth Rate Forecast of In vitro transcription (2020-2025)

Figure Global RNA-interference (RNAi) Market Volume ($) and Growth Rate Forecast of In vitro transcription (2020-2025)

Figure Global RNA-interference (RNAi) Market Value ($) and Growth Rate Forecast of In vivo expression (2020-2025)

Figure Global RNA-interference (RNAi) Market Volume ($) and Growth Rate Forecast of In vivo expression (2020-2025)

Table Global Market Value ($) Forecast by Application (2020-2025)

Table Global Market Volume Forecast by Application (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Drug Discovery and Development (2020-2025)

Figure Market Volume and Growth Rate Forecast of Drug Discovery and Development (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Therapeutics (2020-2025)

Figure Market Volume and Growth Rate Forecast of Therapeutics (2020-2025)

Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure North America Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Europe Consumption and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure South America Consumption and Growth Rate Forecast (2020-2025)

Figure Porter’s Five Forces Analysis

Table New Entrants SWOT Analysis

Table New Project Analysis of Investment Recovery

RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.
The RNA-interference (RNAi) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the RNA-interference (RNAi) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The RNA-interference (RNAi) market can be split based on product types, major applications, and important countries as follows:

Key players in the global RNA-interference (RNAi) market covered in Chapter 12:
Tekmira Pharmaceuticals Corporation
Phio Pharmaceuticals Corp.
Quark Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Dicerna Pharmaceuticals
Silence Therapeutics PLC
Qiagen NV
Arrowhead
Merck & Co. Inc. (Sigma Aldrich)
ISIS Pharmaceuticals
Alnylam Pharmaceuticals
Thermo Fisher Scientific Inc.
Benitec Biopharma Ltd
Arcturus Therapeutics
RXI Pharmaceuticals

In Chapter 4 and 14.1, on the basis of types, the RNA-interference (RNAi) market from 2015 to 2025 is primarily split into:
Chemical synthesis
In vitro transcription
In vivo expression

In Chapter 5 and 14.2, on the basis of applications, the RNA-interference (RNAi) market from 2015 to 2025 covers:
Drug Discovery and Development
Therapeutics

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025